Elanco Animal Health Incorporated revised earnings guidance for the year 2022. For the year, Revenue of $4,385 million to $4,430 million against previous guidance of $4,465 million to $4,550 million and Reported LPS of $0.17 to $0.12 against previous guidance of $0.10 to $0.03.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.3 USD | +0.77% | -0.46% | +8.89% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.89% | 7.97B | |
-13.61% | 77.16B | |
+4.62% | 3.09B | |
-3.62% | 3.07B | |
-21.25% | 1.31B | |
+9.80% | 1.29B | |
-20.24% | 1.29B | |
-3.52% | 1.28B | |
-14.08% | 1.11B | |
+4.89% | 971M |
- Stock
- Equities
- Stock Elanco Animal Health Incorporated - Nyse
- News Elanco Animal Health Incorporated
- Elanco Animal Health Incorporated Revises Earnings Guidance for the Year 2022